Valuation : Cipla Limited

Market Cap 1,109B 11.6B 9.98B 9.42B 8.58B 16.03B 16.18B 112B 43.16B 563B 43.57B 42.62B 1,787B P/E 2027 *
26.7x
P/E 2028 * 21.6x
Enterprise Value 1,003B 10.49B 9.03B 8.52B 7.76B 14.5B 14.63B 101B 39.03B 509B 39.41B 38.55B 1,616B EV / Sales 2027 *
3.24x
EV / Sales 2028 * 2.82x
Free-Float
68.87%
Yield 2027 *
0.95%
Yield 2028 * 1.07%
1 day-0.53%
1 week-1.37%
Current month-3.07%
1 month-6.63%
3 months-1.25%
6 months+2.75%
Current year-9.61%
1 week 1,347.7
Extreme 1347.7
1,398.4
1 month 1,347.7
Extreme 1347.7
1,474.3
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Director of Finance/CFO - 2026-07-23
President - 2026-05-17
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.37%-12.48%+9.51% 11.6B
-1.13%-3.11%+14.31%+61.84% 46.7B
-1.13%-5.78%+34.89%+111.91% 39.11B
+0.12%-0.08%+7.23%+78.04% 11.66B
0.00%+0.38%+20.28%+137.27% 9.19B
+0.08%-2.50%+23.03%+32.91% 7.27B
+0.17%-0.74%+13.70%+198.32% 7.13B
-1.00%-5.25%+33.87%-18.63% 7.15B
-1.43%-1.37%-43.32%+21.01% 5.13B
+0.38%+1.98%+37.38%+104.43% 4.6B
Average -0.45%-2.62%+12.89%+73.66% 14.95B
Weighted average by Cap. -0.76%-3.49%+17.49%+77.94%

Financials

2027 *2028 *
Net sales 310B 3.24B 2.79B 2.63B 2.4B 4.48B 4.52B 31.32B 12.06B 157B 12.17B 11.91B 499B 347B 3.63B 3.12B 2.95B 2.69B 5.02B 5.07B 35.1B 13.51B 176B 13.64B 13.34B 560B
Net income 41.35B 433M 372M 351M 320M 598M 603M 4.18B 1.61B 20.98B 1.62B 1.59B 66.63B 51.42B 538M 462M 436M 398M 743M 750M 5.2B 2B 26.08B 2.02B 1.98B 82.83B
Net Debt -106B -1.11B -954M -900M -820M -1.53B -1.55B -10.72B -4.13B -53.8B -4.17B -4.08B -171B -131B -1.37B -1.18B -1.12B -1.02B -1.9B -1.92B -13.29B -5.11B -66.67B -5.16B -5.05B -212B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-09-11 1,366.00 -0.53% 1,681,155
26-09-10 ₹1,373.30 +0.75% 826,221
26-09-09 ₹1,363.10 -1.51% 818,773
26-09-08 ₹1,384.00 -0.79% 728,795
26-09-07 ₹1,395.00 +0.72% 606,497
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,373.30INR
Average target price
1,509.08INR
Spread / Average Target
+9.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!